皮膚糸状菌症:疫学予測(~2028年)

◆英語タイトル:Dermatophytic Onychomycosis: Epidemiology Forecast to 2028
◆商品コード:GDATA20MY1136
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年1月31日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,995 ⇒換算¥419,475見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD7,990 ⇒換算¥838,950見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD11,985 ⇒換算¥1,258,425見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Dermatophytic Onychomycosis: Epidemiology Forecast to 2028
Summary

Dermatophytic onychomycosis (DO) is a form of chronic fungal infection of the nails caused by dermatophytes, a type of fungi that requires keratin for growth (Aly, 1994; Elewski, 1998). The disease can occur in both fingernails and toenails, though it is most commonly found affecting the toes, and predominantly affects adults ages 30-60 years (Elewski and Charif, 1997). Symptoms of this disease can include nail discoloration, thickening of the nail, splitting of the nail, separation of the nail from the nail bed, and overall discomfort in the affected area (Rogers and Bassler, 2001).

In 2018, there were 24,061,831 total prevalent cases of DO and 9,624,733 diagnosed prevalent cases of DO in the US, in men and women, combined for all ages. By 2028 these numbers are expected to grow to 31,498,328 and 12,599,329, respectively. Men accounted for more than 60% of the cases in the US in 2018 and adults ages 60-69 years comprise the largest number of cases in the ten-year age groupings captured in this forecast, with more than 30% of the diagnosed prevalent cases of DO.

GlobalData’s forecast is strengthened by the use of peer-reviewed publications to forecast the total prevalent cases of DO in the US. Additionally, this forecast is strengthened by the US of primary market research, through a prescriber survey, to estimate the diagnosis rate of DO in the US.

Scope

- The Dermatophytic Onychomycosis (DO) Epidemiology Report provides an overview of the risk factors and historical trends of DO in the US.
- This report provides an overview of the risk factors and the global and historical trends for DO in the US. It also includes a 10-year epidemiology forecast of the total and diagnosed prevalent cases of DO in the US from 2018 to 2028.
- The diagnosed prevalent cases are further segmented by sex and age (in ten year age groups starting at 0 years and up to 80 years and older).
- The DO epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the US.
- The Epidemiology report is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the report supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The DO Epidemiology series will allow you to –
- Develop business strategies by understanding the trends shaping and driving the DO market in the US.
- Quantify patient populations in the US DO market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DO therapeutics in in the US.

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Dermatophytic Onychomycosis: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for DO (2018-2028)
3.5.1 Total Prevalent Cases of DO
3.5.2 Diagnosed Prevalent Cases of DO
3.5.3 Sex-Specific Diagnosed Prevalent Cases of DO
3.5.4 Age-Specific Diagnosed Prevalent Cases of DO
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
4 Appendix
4.1 Bibliography
4.2 Primary Research – Prescriber Survey
4.3 About the Authors
4.3.1 Epidemiologist
4.3.2 Reviewers
4.3.3 Global Director of Therapy Analysis and Epidemiology
4.3.4 Global Head and EVP of Healthcare Operations and Strategy
4.4 About GlobalData
4.5 Contact Us
4.6 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for DO
Table 4: High-Prescribing Physicians (non-KOLs) Surveyed, By Country

【掲載企業】



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[皮膚糸状菌症:疫学予測(~2028年)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆